Wenbao Wang

机构：Baylor Scott & White Health, Qiqihar Medical University · ORCID：0000-0002-3525-3265

发表论文 99 篇 · 总被引 2044 次 · h-index 24

代表论文

• Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1/RIP3/MLKL pathway to induce necroptosis (2021 · European Journal of Medicinal Chemistry · 被引 36)
• The Graphene Quantum Dots Gated Nanoplatform for Photothermal-Enhanced Synergetic Tumor Therapy (2024 · Molecules · 被引 21)
• Novel diosgenin–amino acid–benzoic acid mustard trihybrids exert antitumor effects via cell cycle arrest and apoptosis (2021 · The Journal of Steroid Biochemistry and Molecular Biology · 被引 13)
• Research on the impact of the ESG rating divergence of manufacturing firms on carbon emission intensity (2025 · PLoS ONE · 被引 10)
• Design, synthesis and biological evaluation of novel diosgenin–benzoic acid mustard hybrids with potential anti-proliferative activities in human hepatoma HepG2 cells (2022 · Journal of Enzyme Inhibition and Medicinal Chemistry · 被引 10)
• Investigating disturbances of the core material system in the lung-gut axis of COPD based on the transcriptomics-metabolomics-microbiomics integration strategy (2024 · Arabian Journal of Chemistry · 被引 4)